In the other Trends
All living orgamsms have an intricate network of systems whose role is to repair damage to DNA. One of the most important of these, nucleotide excision repair (NER), is a five-step pathway that eliminates a variety of structurally unrelated lesions, including UVinduced cyclobutane pyrimidine dimers (CPD) and (6--4) photoproducts, many types of chemical adducts and DNA crosslinks. As summarized in part I of this review t, the mechanism of NER is best understood in the bacterium E. coli. In part II, I focus on the more complex pathway in eukaryotes, about which much less is known. I shall discuss the main features and biological impact of NER in mammals, and attempt to put these into an evolutionary and mechanistic perspective by comparing mammalian NER with the yeast system. For a comprehensive review on DNA repair in general, see Ref. 2 .
General characteristics of mammalian NER
Each mammalian nucleus contains approximately two metres of DNA and repair systems face a formidable task in surveying this for the presence of lesions. This logistic problem seems to be reduced to some extent by the preferential (i.e. more rapid and complete) repair of transcribed sequences, a process that is carried out by a special NER subpathway also round in E. coli and yeast 3. Apparently, high priority is given to rapid resumption of transcription when this vital process is blocked by lesions in the template. The initial recognition and signalling of DNA injury in this subpathway is probably performed by RNA polymerase, whereas in the more slow and incomplete 'overall genome' NER subpathway, lesions are thought to be detected by repair complexes scanning the DNA. The screening for conformational abnormalities by RNA polymerase II may be more rigorous and this may explain why some lesions, such as CPDs, are more efficiently removed from transcribed strands than from the rest of the genome3. Other lesions, such as 6-4 photoproducts, are already very efficiently recognized by the overall genome repair system. Their rate of removal from the bulk of DNA is almost the same as that achieved by transcription-coupled repair.
Human NEll-deficient syndromes
The consequences of deficient excision repair are apparent from the clinical symptoms of the human repair disorders xeroderma pigmentosum (XP), Cockayne's syndrome (CS) and PIBIDS, a special form of trichothiodystrophy. Patients suffering from one of these rare autosomal recessive diseases are very sensitive to sun (UV) light. XP patients show pigmentation abnormalities and numerous premalignant lesions in sun-exposed skin, as well as a predisposition to skin cancer and, often, accelerated neurodegeneration. Neurological dysfunction is also a hallmark PIBIDS is an acronym for a complex syndrome that comprises photosensitivity, ichthyosis (scaling of the
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Micrograph showing complementation of the DNA-repair defect in XP. Fibroblasts from two XP patients were labelled with latex beads of different diameter and fused using inactivated Sendal virus. Cells were then UV-irradiated and subsequently incubated in the presence of 3HTdR. Unscheduled DNA repair. synthesis (UDS) was visualized using in situ autoradiography. The number of autoradiographic grains over each nucleus reflects the repair capacity of the cell. The nonfused monokaryons (of complementation group C and G) show UDS that is greatly reduced (XP-C) or completely absent (XP-G). The heterodikaryon, which contains both types of latex beads, has a normal level of UDS. 
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*Unscheduled DNA synthesis as a imrc, ntage of wild-type activity. skin), brittle hair, impaired intelligence, decreased fertility, and short stature. PIBIDS resembles CS in many aspects: its effects on growth, the nervous system 7, sexual development and photosensitivity, and in its lack of association with cancer. Brittle hair, caused by a reduced content of cysteine-rich matrix proteins, is the most prominent characteristic of trichothiodystrophy, a disorder that also affects patients who are not photosensitive (reviewed in Ref. 6 ).
NER deficiency is reflected at the cellular level as hypersensitivity to UV and to agents that mimic the effect of UV; in most XP and PIBIDS patients, UVinduced unscheduled DNA synthesis (UDS) is also slower or completely absent 4. The NER defect in classical CS is limited to the subpathway of preferential repair of (the transcribed strand of) active genes; the less efficient 'overall genome' repair system is still functional s. Since preferential repair makes a relatively small contribution to the total repair synthesis, CS fibroblasts show near-normal levels of UDS. However, the preferential repair defect prevents the rapid recovery of RNA synthesis after UV exposure and this probably causes the increased UV sensitivity.
Complementation analysis shows that all three NER disorders are genetically heterogeneous: fusion of cells from different patients can complement each repair defect. An example of XP complementation is shown in Fig. 1 . Seven excision-deficient XP complementation groups (designated XP-A to XP-G) have been catalogued to date0 (Table 1 ). An eighth group, called XPvariant, has normal NER but is thought to be impaired in the poorly defined postreplication repair pathway 1°, Patients who have CS only fall into one of two complementation groups 6, CS-A or CS-B, whereas a number of very rare individuals with combined manifestations of XP and CS fall into XP groups B, D and G (Ref. 9 and our unpublished results; Table 1 Repair deficiency is most severe in XP groups A, B and G, and affects both overall genome and preferential repair. In XP-C the excision defect is limited to the overall genome pathway 14, thus XP-C is the biochemical opposite of CS-A and CS-B. Since the efficiency of overall genome repair has a strong impact on mutagenesis, this may explain the high incidence of skin aThe number of plus signs indicates the sensitivity of the mutant relative to wild-tylx~ cells: +, 2-5 times greater; +% 5-10 times greater; +++, more than 10 times greamt than wild-type sensitivity.
cancer associated with XP-C, and the lower risk for CS.
As mentioned above, XP-D is a very heterogeneous group that includes XP, XP/CS and PIBIDS patients 12.
NER is least affected in XP-E. Finally, repair in the mild XP group F appears to be slow, but ultimately quite complete. In all XP complementation groups, the defects in repair of CPD lesions can be bypassed by introducing the prokaryotic CPD-specific endonucleases of bacteriophage T4 and Mfcrococcus iuteus (Ref. 15 , and references therein). Apparently, when incision of the damaged strand has been carried out by exogenous enzymes, the cellular repair machinery is capable of completing the task. This suggests -but does not necessarily prove -that all XP defects reside in NER steps preceding incision or affecting incision itself, and implies that the first stage of the reaction is quite complex.
Rodent ~ mutants A second important category of mammalian mutants are the laboratory-induced, UV-sensitive rodent cell lines. These are mainly derived from Chinese hamster ovary (CHO) cell lines, and there are currently 11 NER complementation groups in this class of mutants 16. Their main features are summarized in Table 2 (reviewed in Ref. 17) . Mutants that belong to the first five groups are extremely sensitive to UV and bulky adducts and in that respect resemble the XP groups A, B, D and G. Repair in the few representatives of the remaining groups appears to be only partially disturbed, as in CS-A and CS-B and in XP groups C, E and F. A unique characteristic of groups 1 and 4 is their extraordinary sensitivity to cross-linking agents. This suggests that the NER genes affected in these mutants act in additional systems that repair or respond to cross-link damage in DNA. As shown below, there is considerable overlap between the Chinese hamster mutants and the human NER syndromes.
HumanNERgenes
So far, most mammalian NER genes have been isolated by transfection of genomic DNA into INsensitive rodent repair mutants m, followed by selection of IN-resistant transformants and retrieval of the correcting sequence. Recendy, however, the use of eDNA expression libraries in extrachromosomally replicating vectors based on the Epstein-Barr virus t9 has circumvented many of the problems that previously limited the use of human cells for transfection.
The human genes correcting rodent repair defects are called ERCC genes, for excision repair crosscomplementing rodent repair deficiency genes. The number refers to the rodent group that is corrected. It has yet to be established whether XP-C has a corresponding rodent mutant. The extensive ovedap between human syndromes and rodent mutants stresses the value of the latter class for understanding the molecular basis of repair defects in humans.
Overlap between mammalian and yeast genes
Except for ERCC6 and possibly XPCC, all human genes have identified counterparts in the yeast system 26,~-33 (Table 3) , with the level of sequence identity between corresponding yeast and mammalian proteins ranging from 25% to over 50%. XPCC may be equivalent to RAD4, but the region of similarity comprises only one quarter of the protein 19. Furthermore, the NER defects of XP-C (preferential repair unaffected) and rad4 (total NER deficiency) appear to differ. The ERCC1 gene product shows a remarkable pattern of homology with RAD10. The first 214 amino acids align with the entire 210 amino acid RAD10 polypeptide29; of the remaining 83 residues, the first part shows some homology with a segment of the E. coli NER protein UvrA, while the 60 carboxy-terminal residues strongly resemble the carboxy terminus of UvrC.
Encoded functions
XPAC. The purified XPAC protein has an affinity for single-stranded (ss) DNA as well as IN-irradiated double-stranded (ds) DNA34,3s and contains a predicted DNA-binding zinc-finger domain36. Its preference for binding to IN-induced lesion# 4 may implicate XPAC in damage recognition. From the nature of the XP-A repair defect as measured in the in vitro NER assay (see below), the protein is expected to function in a preincision step of NER (Ref. 37) . In a number of XP-A patients, the XPAC gene contains aberrant splicing signals and nonsense codons, many of which are expected to completely inactivate it (Ref. 38 and references therein). In general, there is a good correlation between the severity of the mutation and the severity of the clinical features.
XPCC Unfortunately, the predicted 823 amino acid sequence of XPCC does not provide interpretable clues to its function. The absence of XPCC mRNA in many XP-C patients suggests that complete inactivation of the gene is not lethal tg.
ERCC1. Deletion analysis of ERCC1 indicates that the five carboxy-terminal amino acids of the protein residing in a region that has significant homology with the carboxyl terminus of Uvr C, are indispensable for its repair function (our unpublished observations). The corresponding part of Uvr C is similarly essential39. Another parallel between ERCC1 and UvrC is that absence of the entire amino-terminal region appears not to have a drastic effect on the repair function of the proteins. There is recent evidence that ERCC1 resides in a complex with several other NER proteins: the products of the as yet uncloned ERCC4, ERCCll "rig .IUNE 1993 VOL. 9 NO. 6
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and XPFC genes (our unpublished results). Since group 1 and 4 mutants, unlike other rodent NER mutants, are extremely sensitive to crosslinking agents, the ERCC1 complex may also play a role in the repair of (a subset of) DNA cross links. One of the partners of ERCC1 in this complex could be the human counterpart of RADI: the yeast protein is tightly associated with the ERCC1 homologue, RADIO (Ref. 1). The role of these proteins in mitotic recombination, and the presumed ability of RAD1 to remove regions of non-homology from the 3' end of recombining DNA molecules t, are compatible with the idea that this complex may be responsible for, or associated with, incision, and (when required for the elimination of interstrand cross links) with an additional recombination step. (1) ERCC2 and ERCC3 mutants are very similar; (2) The proteins have a similar degree of sequence conservation with their yeast cognates RAD3 and RAD25/SSL2 (Refs 30-32).
(3) The proteins are of similar size and their seven 'helicase' motifs suggest a DNA-unwinding function (Fig. 2) . Very recently, evidence for helicase activity of ERCC3 has been obtained 41. The ERC~'3 gene product was identified by Egly and co-workers 4] as one of the components of the human TFIIH/BTF2 transcription factor, which is required for initiation of transcription of genes by RNA polymerase II. Highly purified fractions of TFIIH have an ATP-dependent helicase activity strongly associated with the ERCC3 subunit of the complex 4]. Other evidence for a role for ERCC3 in gene expression has come from the yeast gene RAD25/SSL2 (Ref. 1) and from the work of Mounkes et aL 4z, who have identified the Drosophila homologue of ERCC3 as the gene mutated in haywire mutants. These mutants show various defects including male-sterility, which is thought to be caused by reduced expression of the B2t tubulin gene required for normal spermatogenesis 42.
A role for ERCC3 in transcription (and subtle defects in this process caused by mild mutations in the gene) may explain some of the clinical symptoms of XP-B that are not easily accounted for by the NER defect. These include the severe growth defect and the dysmyelination of neurons. The latter phenotype may be related to the expression level of the myelin basic protein that, at least in mice, critically determines the degree of CNS myelination 43. This suggests that defects in group XP-B represent, at least in part, a transcription syndrome.
An important question remains: how can ERCC3 be involved in both transcription and nucleotide excision? Two options can be envisaged. The simplest interpretation is that ERC.~3 catalyses a DNA unwinding step both in transcription initiation and in NER. A second possibility is that ERCC3 functions only in transcription initiation, and that some mutations in the protein have an adverse effect on the transcription of one or more DNA repair genes, indirectly resulting in a NER defect3t. One would then have to assume that the strict dependence of such a repair gene on optimal functioning of ERCC3 has been preserved in eukaryotic evolution from yeast to Drosophila and to humans.
Considering the remarkable similarities between ERCC2 and ERCC3, it is tempting to speculate that these proteins act together in the same step of transcription initiation and the NER reaction, perhaps forming a helicase complex required for local melting of the double helix, to allow entry of RNA polymerase or NER proteins, and/or their translocation along the DNA template z*. Evidence that supports the latter function for RAD3 has been reported recently ~. As schematically depicted in Fig. 3 , the XPAC protein and/or the protein mutated in XP-E (Ref. 45 ) might also constitute part of such a complex. It is also possible that ERCC2 and ERCC3 are required for release of the damage-containing oligonucleotide after incision, and turnover of bound NER proteins. Speculative model for the concerted action of the presumed ERCC2 and ERCC3 helicases and the postulated damage recognition protein XPAC in scanning DNA for structural distortions. The XP-E protein might also participate in this complex, as it also has damage-specific DNA binding activity 4s.
100 and 140 amino acid residues showed a high degree of homology with an open reading frame on chromosome XI of S. cerevisiae, the function of which is not known 26,27. Unfortunately, the primary sequences of these RAD2 family members yield few clues to their possible function in NER. ERCC6. The predicted sequence of the 1493 amino acid protein ERCC6, which belongs to the RAD16 subfamily, again reveals putative helic.lse domains z'~. The anticipated nucleic acid unwinding activity of ERCC6 should fit into the mechanism of 'he strand-selective repair of active genes that is defective in CS-B. At least two possibilities (or a combination of these) can be envisaged. First, the protein may be involved in scanning the transcribed strand ['or a blocked RNA polymerase, thus guiding the NER machinery to lesions that thwart transcription. Second, the DNA or DNA/RNA unwinding activity may be involved in unwinding the RNA-DNA duplex closely behind the transcription complex, thus dtssociating it from the template and removing steric hindrance to the lesion. These speculative models can be tested by biochemical experiments using the purified proteins and a bona fide in vitro repair assay system.
Mammalian NER in vilro
An in vitro NER assay using cell-free extracts promises to help resolve the reaction mechanism of mammalian NER (Refs 46, 47) . This system permits the use of defined, damaged DNA substrates and purified proteins or antibodies to dissect the reaction into discrete steps and to determine the components involved. Fractionation of cell extracts has revealed that many factors, including the XP-A protein and human single-stranded binding protein (HSSB), are required for the generation of incised intermediates37. Recent analysis of the products of incision has demonstrated that, as in E. coil, an asymmetric dual incision is made in a damaged template 4s. The 5' incision in human NER is made further upstream, and one or two nucleotides more 3' of the injury than in E. coli, generating a 29 bp lesioncontaining oligonucleotide ~s. After incision, DNA synthesis is apparently carried out by DNA polymerase 8 or e, since this reaction is dependent on the proliferating cell nuclear antigen 37 (PCNA). DNA polymerase 8 is normally implicated in leading strand synthesis of semi-conservative DNA replication. These findings therefore reveal that part of the replication machinery, is also used in repair reactions, and illustrate that there is considerable overlap between these fundamental processes that metabolize DNA.
Concluding remarks
The known or postulated properties of the eukaryotic NER genes, and analogy with the main steps of the E. coli pathway, suggest the following scenario for NER in mammals:
(1) The ERCC2/ERCC3/XPAC and possibly XPEC proteins are involved in detection of lesions, with the helicases scanning the DNA helix, and XPAC and XPEC recognizing the lesion. ERCC2 may also be implicated in this step.
(2) Upon encountering a lesion, the complex locally denatures the DNA; this specific denatured conformation is recognized by the ERCC1/ERCC4/ERCCll/ XPFC complex, which performs the dual incision. The Uvr C-like carboxy terminus of ERCC1 could play an important role in this reaction.
(3) HSSB, PCNA and DNA polymerase are involved in removal of the damage-containing oligonucleotide, turn over of the incision complex and resynthesis of DNA.
Future research will undoubtedly reveal whether this speculative scenario bears any relation to the actual situation within the cell. Although complete elucidation of the eukaryotic NER reaction mechanism may still seem far away, the contours of the systems are beginning to emerge from the pieces of the puzzle that have already been identified; the yeast model is expected to be of great importance because of its versatility and relative simplicity. Furthermore, valuable tools are available in the form of in vitro repair assay systems.
Finally, we should soon see the NER genes that have already been cloned being used to generate repair-deficient tmnsgenic mice by targeted gene inactivation. Such mouse models may yield valuable insight into how the molecular defect is translated into clinical features, such as predisposition to cancer, and into the origin of the clinical heterogeneity observed in human disorders. They may also prove very important for studies related to ageing, neurodegeneration and assessment of the genotoxicity of mutagenic agents.
